Clinical Assessment of Spatial Neglect Following Stroke
Launched by LANDSPITALI UNIVERSITY HOSPITAL · Aug 27, 2019
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying spatial neglect (SN), a condition that can occur after a stroke. Spatial neglect means that a person may not notice or pay attention to one side of their body or their surroundings, which can make recovery more difficult. The researchers from Iceland and Lithuania want to find the best ways to identify SN in patients so that appropriate help can be provided.
To participate in this trial, you need to be at least 18 years old and have had a stroke confirmed by a CT or MRI scan. You also need to live in either Iceland or Lithuania and be able to give informed consent, which means you understand what the study involves. Participants will undergo assessments to see if they have spatial neglect and will contribute to important research that could improve care for stroke survivors. If you or someone you know fits these criteria and is interested, joining this trial could be a valuable opportunity to help advance our understanding of stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stroke diagnosis confirmed by results of CT/MRI.
- • Lives in Iceland or Lithuania.
- • 18 year or older.
- • Informed consent provided by patient or proxy.
- Exclusion Criteria:
- • • Patients receiving end-of-life care
About Landspitali University Hospital
Landspítali University Hospital is a leading medical institution in Iceland dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates academic excellence with patient care, fostering collaborations among healthcare professionals, researchers, and academic institutions. Its commitment to improving patient outcomes is reflected in its rigorous adherence to ethical standards and regulatory compliance. Landspítali University Hospital aims to contribute to the global medical community by exploring new therapies and treatment modalities, ultimately enhancing the quality of care for patients both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reykjavík, , Iceland
Patients applied
Trial Officials
Marianne Klinke
Principal Investigator
Landspitali
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials